Concepedia

The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques—implications for recombinant vaccine design

Philip A. Mudd, Shari M. Piaskowski, Patrícia Neves, Richard Rudersdorf, Holly L. Kolar, Christopher M. Eernisse, Kim L. Weisgrau, Marlon G. Veloso de Santana, Nancy A. Wilson, Myrna C. Bonaldo,

Immunogenetics · 2010 · 22 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Troy D. Querec, Rama Akondy, Eva K. Lee et al. · Nature Immunology · 2008 · 1.1K citations · Full text

, , +14

Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

Jonathan W. Yewdell, Luis C. Antón, Jack R. Bennink · The Journal of Immunology · 1996 · 452 citations

, , +17

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

Rama Akondy, Nathan D. Monson, Joseph D. Miller et al. · The Journal of Immunology · 2009 · 349 citations · Full text

, , +17

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

Jack D. Poland, Charles H. Calisher, Thomas P. Monath et al. · PubMed · 1981 · 307 citations

, , +15

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

Chang S. Hahn, Joel M. Dalrymple, J H Strauss et al. · Proceedings of the National Academy of Sciences · 1987 · 253 citations · Full text

, , +17